Synthetic retinoid CD437 induces cell-dependent cycle arrest by differential regulation of cell cycle associated proteins

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2757-2764

  Shyu, Rong Yaun ^a   Lin, Ding Yen ^b   Reichert, Uwe ^c   Jiang, Shun Yuan ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c Galderma R and D   (France)

Author keywords

CD437; Cell cycle; Cyclin dependent kinase; Cyclin dependent kinase inhibitor; Gastric cancer; Retinoids

Indexed keywords

6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; CELL CYCLE PROTEIN; CELL DNA; CYCLIN DEPENDENT KINASE; HISTONE H1; PROTEIN P21; RETINOID DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STOMACH CANCER;

ANTINEOPLASTIC AGENTS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; FLOW CYTOMETRY; GROWTH INHIBITORS; HUMANS; RETINOIDS; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036765969     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Giguere V: Retinoid acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocrine Rev 15: 61-78, 1994
2. Leblanc BP and Stunnenbery HG: 9-Cis retinoic acid signaling: changing partners causes some excitement. Genes Dev 9: 1811-1816, 1995.
3. Martin B, Bernardino JM, Cavey MT, Bernard B, Carlavan I, Charpentier B, Pilgrim WR, Shroot B and Reichert U: Selective synthetic ligands for human nuclear retinoic acid receptors. Skin Pharmocol 5: 57-65, 1992.
4. Bernard BA, Bernardon JM, Delescluse C, Martin B, Lenoir MC, Maignan J, Charpentier JB, Pilgrim WR, Reichert U and Shroot B: Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ. Biochem Biophys Res Commun 186: 977-983, 1992.
5. Lehmann JM, Jong L, Fanjul A, Cameron JF, Lu XP, Haefner P, Dawson MI and Pfahl M: Retinoids selective for retinoid X receptor response pathways. Science 258: 1944-1946, 1992.
6. Shao ZM, Dawson MI, Li XS, Rishi AK, Sheikh MS, Han QX, Ordonez JV, Shroot B and Fontana JA: p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 11: 493-504, 1995.
7. Schadendorf D, Kern MA, Artuc M, Pahl HL, Rosenbach T, Fichtner I, Nurnberg W, Stuting S, von Stebut E, Worm M, Makki A, Jurgovsjy K, Kolde G and Henz BM: Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro and causes growth inhibition in xenografts in vivo. J Cell Biol 135: 1889-1898, 1996.
8. Sun SY, Yue P, Dawson MI, Shroot B, Michel S, Lamph WW, Heyman RA, Teng M, Chandraratna RA, Shudo K, Hong WK and Lotan R: Differential effects of synthetic nuclear retinoid receptor- selective retinoids on the growth of human non-small cell lung carcinoma cells. Cancer Res 57: 4931-4939, 1997.
9. Spanjaard RA, Ikeda M, Lee PJ, Charpentier B, Chin WW and Eberlein TJ: Specific activation of retinoic acid receptors (RARs) and retinoid X receptors reveals a unique role for RARg in induction of differentiation and apoptosis of S91 melanoma cells. J Biol Chem 272: 18990-18999, 1997.
10. Hsu CA, Rishi AK, Xiao SL, Gerald TM, Dawson MI, Schiffer C, Reichert U, Shroot B, Poirer GC and Fontana JA: Retinoid induced apoptosis in leukemia cells through a retinoid acid nuclear receptor-independent pathway. Blood 89: 4470-4479, 1997.
11. Liang JY, Fonana JA, Rao JN, Ordonez JV, Dawison MI, Shroot B, Wilber JF and Feng P: Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCap and PC-3. Prostate 38: 228-236, 1999.
12. Jiang SY, Lin DY, Shyu RY, Reichert U and Yeh MY: The RARg selective agonist CD437 inhibits gastric cell growth through the mechanism of apoptosis. Cancer Letters 137: 217-225, 1999.
13. Hsu SL, Yin SC, Liu MC, Reichert U and Ho WL: Involvement of cyclin-dependent kinase activities in CD437-induced apoptosis. Exp Cell Res 252: 332-341, 1999.
14. Szondy Z, Reichert U, Bernardon JM, Michel S, Toth R, Ancian P, Ajzner E and Fesus L: Induction of apoptosis by retinoids and retinoic acid receptor γ-selective compounds in mouse thymocytes through a novel apoptosis pathway. Mol Pharmacol 51: 972-982, 1997.
15. Li Y, Lin B, Agadir A, Liu R, Dawson MI, Reed JC, Fontana JA, Bost F, Hobbs PD, Zheng Y, Chen GQ, Shroot B, Mercola D and Zhang XK: Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines. Mol Cellular Biol 18: 4719-4731, 1998.
16. Zhang Y, Huang Y, Rishi AK, Sheikh MS, Shroot B, Reichert U, Dawson MI, Poirer G and Fontana JA: Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid. Exp Cell Res 247: 233-240, 1999.
17. Norbury C and Nurse P: Animal cell cycles and their control. Annu Rev Biochem 61: 441-470, 1992.
18. Morgan DO: Principles of cdk regulation. Nature 374: 131-134, 1995.
19. Reed SI: Control of the G1/S transition. Cancer Survey 29: 7-22, 1997.
20. Gu Y, Rosenblatt J and Morgan DO: Cell cycle regulation of cdk2 activity by phosphorylation of Thr 160 and Tyr 15. EMBO J 11: 3995-4005, 1992.
21. Sebastian B, Kakizuka A and Hunter T: Cdc25M2 activation of cyclin dependent kinases by dephosphorylation of threonin-14 and tyrosine-15. Proc Natl Acad Sci USA 90: 3521-3524, 1993.
22. Grana X, Garriga J and Mayol X: Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17: 3365-3383, 1998.
23. Solomon MJ: Activation of the various cyclin/cdc2 protein kinases. Current Opinion Cell Biol 5: 180-186, 1993.
24. Tassan J, Schultz SJ, Bartek J and Nigg EA: Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J Cell Biol 127: 467-478, 1994.
25. cdc2 exclusively on Tyr15. EMBO J 12: 75-85, 1993.
26. cdc2. Cell 65: 197-211, 1991.
27. WAF1/CIP1 expression in human breast cancer carcinoma cells. Cancer Res 56: 5055-5062, 1996.
28. Shyu RY, Jiang SY, Huang SL, Chang TC, Wu KL, Roffler SR and Yeh MY: Growth regulation by all-trans retinoic acid and retinoic acid receptor messenger ribonucleic acids expression in gastric cancer cells. Eur J Cancer 31A: 237-243, 1995.
29. Dulic V, Lees E and Reed SI: Association of human cyclin E with a periodic G1-S phase protein kinase. Science 257: 1958-1961, 1992.
30. Martinez AM, Afshar M, Martin F, Cavadore JC, Labbe JC and Doree M: Dual phosphorylation of the T-loop in cdk7: its role in controlling cyclin H binding and CAK activity. EMBO J 16: 343-354, 1997.